TScan Therapeutics (TCRX) EPS (Diluted) Growth (1y) (2022 - 2026)
TScan Therapeutics (TCRX) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | 22.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.63% |
| Dec 31, 2025 | 40.57% |
| Sep 30, 2025 | -9.24% |
| Jun 30, 2025 | -2.04% |
| Mar 31, 2025 | 10.23% |
| Dec 31, 2024 | -8.40% |
| Sep 30, 2024 | -3.83% |
| Jun 30, 2024 | 45.20% |
| Mar 31, 2024 | 65.89% |
| Dec 31, 2023 | 52.64% |
| Sep 30, 2023 | 64.06% |
| Jun 30, 2023 | 18.82% |
| Mar 31, 2023 | -38.21% |
| Dec 31, 2022 | 41.91% |
| Sep 30, 2022 | 46.97% |
| Jun 30, 2022 | 97.35% |